Cancer Biomarkers

A cancer biomarker refers to an element or procedure that is indicative of the presence of cancer in the body. A biomarker may be a molecule released by a presence of tumour or a specific response of the body to the presence of cancer. Cancer biomarkers are usually biological molecules found in blood, other body fluids, or tissues that are a sign of a normal or abnormal process, or of a condition or disease. Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers can be used for cancer diagnosis, prognosis and epidemiology. The most promising use of biomarkers today is to identify which therapies a patient’s cancer may or may not respond to. So many pharmaceutical companies were producing different sort of biomarkers. So it plays a vital role in the treatment in cancer.

  • Types of Cancer Biomarkers
  • Biomarkers in Drug Discovery
  • Biomarkers in Cancer Screening
  • Biomarkers in Pharmacokinetics
  • Biomarkers in Pharmacodynamics

Related Conference of Cancer Biomarkers

March 09-10, 2026

4th World Congress on Oral Cancer

Singapore City, Singapore
March 30-31, 2026

26th World Congress on Cancer and Diagnostics

London, UK
June 15-16, 2026

10th Global Meeting on Oncology and Radiology

Paris, France
June 22-23, 2026

16th World Congress on Breast Cancer

Dubai, UAE
June 23-24, 2026

27th World Congress on Cancer Summit

Paris, France
July 27-28, 2026

6th World Congress on Breast Cancer

Rome, Italy
September 28-29, 2026

36th Experts Meet On Cancer Research & Therapy

Aix-en-Provence, France
October 05-06, 2026

22nd International Conference on Cancer Research

Madrid, Spain
November 19-20, 2026

44th World Cancer Conference

Dubai, UAE
November 23-24, 2026

7th Cancer Diagnostics & Treatment Conference

Miami, USA

Cancer Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in